news banner
 

pediatric views

other publications

news room

giving

 
 

Clinical Trials

charles

Infants at risk for ASDs or language impairment

This study aims to identify early signs of language or social communication problems that emerge in children at risk for language impairment or autism spectrum disorders. Non-invasive measurements of brain activity and eye movements will be taken.
Eligibility: Infants less than 6 months of age with an older sibling(s) with an ASD or language impairment.

Tara Augenstein at 617-455-7238 or project.infantsibling@gmail.com

Watch Dr. Nelson discuss this study on The Today Show: childrenshospital.org/views/april09/autism




john

TLSOs in the treatment of adolescent idiopathic scoliosis (AIS)

This study aims to determine whether bracing is an effective treatment for patients with AIS by comparing curve progression to surgical threshold in patients randomized to either be "braced" or "watched." The study will also develop a predictive model for curve progression.
Eligibility: Children with a diagnosis of AIS between the ages of 10 and 15 may be eligible.

Ashley Goldthwait at 617-355-2748 or ashley.goldthwait@childrens.harvard.edu




elizabeth

Eye and eyelid movement disorders

The trial defines genes that are mutated in strabismus (lazy eyes) and ptosis (droopy eyelids). Participants will be asked to have either a blood draw or to provide a saliva sample for the genetic study.
Eligibility: Children and adults who were born with an eye movement disorder or droopy eyelids, as well as members of their family.

Click here for a interactive map on eye disorders

Caroline Andrews, MS, at 617-355-7311 or candrews@enders.tch.harvard.edu




 

 
 
  Clinical Trials at Childrenís  

   

Subscribe to our RSS feed

 

 

Email this page to a friend

 

  Contact Us